Alzheimer Drug Lecanemab Gains Traditional FDA Approval

被引：0

|

作者：

Harris, Emily

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年

关键词：

D O I：

10.1001/jama.2023.12548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页数：1

相关论文

共 50 条

[21] Horizon Medical gains FDA approval for catheter
Anon
Urethanes Technology, 2002, 19 (01):
[22] Crixivan gets traditional FDA approval
不详
DRUG NEWS & PERSPECTIVES, 1998, 11 (02) : 125 - 125
[23] Lecanemab: First Approval
Hoy, Sheridan M.
DRUGS, 2023, 83 (04) : 359 - 365
[24] FDA green-lights lecanemab for Alzheimer’s disease
Chemical and Engineering News, 2023, 101 (02)
[25] A lupus drug and FDA approval
Merrill, JT
Raymond, S
SCIENCE, 2005, 308 (5721) : 497 - 497
[26] DRUG APPROVAL PROCESS AND FDA
SCHMIDT, AM
NEW YORK STATE JOURNAL OF MEDICINE, 1976, 76 (12) : 2039 - 2042
[27] FDA AND DRUG APPROVAL PROCESS
KENNEDY, D
CONNECTICUT MEDICINE, 1978, 42 (10) : 651 - 656
[28] Lecanemab: First Approval
Sheridan M. Hoy
Drugs, 2023, 83 : 359 - 365
[29] FDA calls for investigation into industry influence during Alzheimer's drug approval
Dyer, Owen
BMJ-BRITISH MEDICAL JOURNAL, 2020, 374 : n1778
[30] Novartis gains US FDA approval to market Coartem®
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (05) : 504 - 504

← 1 2 3 4 5 →